Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2007-12-05Clinical Trial Update: Study Evaluating Bifeprunox in Bipolar Depression [Phase 3]
Phase 3 study evaluating bifeprunox for bipolar depression has completed.
-
CLINICAL_TRIALS trial_result · 2007-11-16Clinical Trial Update: VALID : VAlproate Versus LIthium in Bipolar Disorders [Phase 4]
A Phase 4 trial comparing valproate to lithium for bipolar disorder has completed.
-
CLINICAL_TRIALS trial_result · 2007-11-09Clinical Trial Update: Phase II Study to Assess RG2417 in the Treatment of Bipolar I Depression [Phase 2]
A Phase II trial of RG2417 for bipolar depression has completed, according to the clinical trials update; no efficacy results are provided i…
-
CLINICAL_TRIALS trial_result · 2007-11-06Clinical Trial Update: Olanzapine Treated Adolescents With Schizophrenia or Bipolar I Disorder [Phase 3]
Phase 3 trial of olanzapine in adolescents with schizophrenia or Bipolar I disorder has been completed. The trial was sponsored by Eli Lilly…
-
CLINICAL_TRIALS trial_result · 2007-11-02Clinical Trial Update: Efficacy and Safety of SPD417 in Treatment of Manic Symptoms in Adults With Bipolar I Disorder [Phase 3]
Phase 3 trial evaluating SPD417 for manic symptoms in adults with Bipolar I Disorder has completed, assessing efficacy and safety.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2007-11-02Clinical Trial Update: Safety of SPD417 Combined With Other Psychotropic Medications in the Treatment of Bipolar I Disorder [Phase 3]
Phase 3 safety update of SPD417 when combined with other psychotropic medications for Bipolar I disorder has completed.
-
FDA approval · 2007-10-31FDA Approved: LITHIUM CARBONATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Lithium carbonate from Hikma Pharmaceuticals USA Inc., signaling a regulatory change to the …
-
FDA approval · 2007-10-05FDA Approved: LITHIUM CARBONATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Lithium carbonate from Hikma Pharmaceuticals USA Inc., finalizing an additional regulatory a…
-
FDA approval · 2007-10-02FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Geodon (ziprasidone mesylate) submitted by Viatris Specialty LLC.
-
FDA approval · 2007-10-02FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
FDA supplemental approval for Geodon (ziprasidone) by Viatris Specialty LLC.
-
FDA approval · 2007-09-28FDA Approved: LITHIUM CARBONATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for lithium carbonate filed by Hikma Pharmaceuticals USA Inc., potentially updating the drug's l…
-
CLINICAL_TRIALS trial_result · 2007-08-24Clinical Trial Update: Abilify Therapy for Reducing Comorbid Substance Abuse [Phase 4]
Phase 4 trial evaluating aripiprazole (Abilify) for reducing comorbid substance use across multiple psychiatric disorders; the study has com…
-
FDA approval · 2007-08-16FDA Approved: TEGRETOL XR — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Tegretol XR (carbamazepine) submitted by Novartis Pharmaceuticals Corporation.
-
FDA approval · 2007-08-16FDA Approved: TEGRETOL — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Tegretol (carbamazepine) filed by Novartis Pharmaceuticals Corporation; the approval updates the…
-
CLINICAL_TRIALS trial_result · 2007-08-14Clinical Trial Update: Safety and Efficacy Study of Lithium in Bipolar Disorder [Phase 3]
An update on a Phase 3 safety and efficacy study of lithium for Bipolar Disorder (Mania) by JDS Pharmaceuticals. The current status of the t…
-
FDA approval · 2007-07-06FDA Approved: ZYPREXA — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for ZYPREXA (olanzapine) from Eli Lilly and Company.
-
FDA approval · 2007-07-06FDA Approved: ZYPREXA ZYDIS — Supplemental Application (Eli Lilly and Company)
FDA Supplemental Application filed for ZYPREXA ZYDIS (olanzapine) by Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2007-07-02Clinical Trial Update: A Study for the Treatment of Mania Associated With Bipolar I Disorder in Children and Adolescents [Phase 3]
A Phase 3 clinical trial studying treatment for mania associated with Bipolar I Disorder in children and adolescents has completed (status: …
-
CLINICAL_TRIALS trial_result · 2007-06-13Clinical Trial Update: Olanzapine Versus Comparator in the Treatment of Bipolar Disorder [Phase 3]
Phase 3 clinical trial comparing olanzapine against a comparator for bipolar disorder has completed.
-
CLINICAL_TRIALS trial_result · 2007-06-13Clinical Trial Update: Olanzapine/Fluoxetine Combination Versus Comparator in the Treatment of Bipolar I Depression [Phase 4]
Phase 4 study comparing the olanzapine/fluoxetine fixed-dose combination (Symbyax) to a comparator for bipolar I depression has been complet…
-
CLINICAL_TRIALS trial_result · 2007-06-12Clinical Trial Update: Olanzapine Versus Placebo in the Treatment of Mania in Adolescents With Bipolar I Disorder [Phase 4]
A Phase 4 trial assessed olanzapine versus placebo for mania in adolescents with Bipolar I disorder; the study has completed.
-
FDA approval · 2007-05-24FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Geodon (ziprasidone mesylate) submitted by Viatris Specialty LLC.
-
FDA approval · 2007-05-24FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Geodon (ziprasidone) submitted by Viatris Specialty LLC.
-
CLINICAL_TRIALS trial_result · 2007-05-23Clinical Trial Update: Family Workshops for Bipolar Disorder [Phase 1]
A Phase 1 clinical trial evaluating family workshops as an intervention for bipolar disorder has completed.
-
CLINICAL_TRIALS research · 2007-05-22Clinical Trial Update: AIMHI NT Relapse Prevention Trial [NA]
AIMHI NT Relapse Prevention Trial update (NCT00192582) sponsored by Menzies School of Health Research with listed conditions including schiz…